3-triazolyl-galactoside inhibitors of galectins
US7700763B2 · kind B2 · utility
12Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2006 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Dec 30, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal. Said galectin is preferably a galectin-3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.